Rank | Gene Set | Z-score |
---|---|---|
1 | axon ensheathment in central nervous system (GO:0032291) | 5.98713930 |
2 | central nervous system myelination (GO:0022010) | 5.98713930 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.37339746 |
4 | L-phenylalanine catabolic process (GO:0006559) | 5.37339746 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.93808872 |
6 | L-phenylalanine metabolic process (GO:0006558) | 4.93808872 |
7 | fatty acid elongation (GO:0030497) | 4.64606569 |
8 | alpha-linolenic acid metabolic process (GO:0036109) | 4.44844320 |
9 | regulation of early endosome to late endosome transport (GO:2000641) | 4.13363490 |
10 | ensheathment of neurons (GO:0007272) | 4.04735701 |
11 | axon ensheathment (GO:0008366) | 4.04735701 |
12 | myelination (GO:0042552) | 4.00522916 |
13 | myelin maintenance (GO:0043217) | 3.96359336 |
14 | aromatic amino acid family catabolic process (GO:0009074) | 3.90281941 |
15 | barbed-end actin filament capping (GO:0051016) | 3.86829536 |
16 | creatine metabolic process (GO:0006600) | 3.81356420 |
17 | glyoxylate metabolic process (GO:0046487) | 3.79441745 |
18 | stress fiber assembly (GO:0043149) | 3.76492372 |
19 | response to methylmercury (GO:0051597) | 3.61285817 |
20 | very long-chain fatty acid metabolic process (GO:0000038) | 3.58848098 |
21 | bile acid biosynthetic process (GO:0006699) | 3.57343256 |
22 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.50104486 |
23 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.49795761 |
24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.44846318 |
25 | skin morphogenesis (GO:0043589) | 3.42484398 |
26 | Golgi transport vesicle coating (GO:0048200) | 3.33840349 |
27 | COPI coating of Golgi vesicle (GO:0048205) | 3.33840349 |
28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.33831583 |
29 | aspartate family amino acid catabolic process (GO:0009068) | 3.32487007 |
30 | epithelial cell-cell adhesion (GO:0090136) | 3.31869576 |
31 | adherens junction assembly (GO:0034333) | 3.30547613 |
32 | acetyl-CoA metabolic process (GO:0006084) | 3.29587516 |
33 | semaphorin-plexin signaling pathway (GO:0071526) | 3.27729495 |
34 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.24915667 |
35 | heme transport (GO:0015886) | 3.23239155 |
36 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.22799898 |
37 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.22520853 |
38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.22164940 |
39 | protein carboxylation (GO:0018214) | 3.22164940 |
40 | pinocytosis (GO:0006907) | 3.20383469 |
41 | protein retention in ER lumen (GO:0006621) | 3.20153963 |
42 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.19748050 |
43 | apoptotic cell clearance (GO:0043277) | 3.19424529 |
44 | short-chain fatty acid metabolic process (GO:0046459) | 3.18522400 |
45 | plasma lipoprotein particle clearance (GO:0034381) | 3.17385073 |
46 | endodermal cell differentiation (GO:0035987) | 3.14942883 |
47 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.13850861 |
48 | regulation of triglyceride catabolic process (GO:0010896) | 3.09601299 |
49 | bile acid metabolic process (GO:0008206) | 3.08285958 |
50 | focal adhesion assembly (GO:0048041) | 3.07571666 |
51 | cell-substrate adherens junction assembly (GO:0007045) | 3.07571666 |
52 | cellular ketone body metabolic process (GO:0046950) | 3.06211914 |
53 | regulation of extracellular matrix disassembly (GO:0010715) | 3.05913732 |
54 | fatty acid beta-oxidation (GO:0006635) | 3.05578810 |
55 | acyl-CoA biosynthetic process (GO:0071616) | 3.05479924 |
56 | thioester biosynthetic process (GO:0035384) | 3.05479924 |
57 | negative regulation of fibrinolysis (GO:0051918) | 3.04018337 |
58 | coenzyme catabolic process (GO:0009109) | 3.03996770 |
59 | positive regulation of extracellular matrix organization (GO:1903055) | 3.01650412 |
60 | cell-substrate junction assembly (GO:0007044) | 3.00608562 |
61 | ethanol oxidation (GO:0006069) | 3.00028799 |
62 | cell adhesion mediated by integrin (GO:0033627) | 2.99469211 |
63 | lysine metabolic process (GO:0006553) | 2.97857006 |
64 | lysine catabolic process (GO:0006554) | 2.97857006 |
65 | regulation of lipoprotein metabolic process (GO:0050746) | 2.97540795 |
66 | kynurenine metabolic process (GO:0070189) | 2.96958798 |
67 | cysteine metabolic process (GO:0006534) | 2.96681640 |
68 | response to mercury ion (GO:0046689) | 2.94738582 |
69 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.94433043 |
70 | cholesterol biosynthetic process (GO:0006695) | 2.93889983 |
71 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.92987128 |
72 | cortical actin cytoskeleton organization (GO:0030866) | 2.92697605 |
73 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.91438816 |
74 | basement membrane organization (GO:0071711) | 2.90900414 |
75 | fatty acid catabolic process (GO:0009062) | 2.90414678 |
76 | regulation of cholesterol metabolic process (GO:0090181) | 2.89671248 |
77 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.88307877 |
78 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.88197719 |
79 | high-density lipoprotein particle remodeling (GO:0034375) | 2.86307018 |
80 | complement activation, alternative pathway (GO:0006957) | 2.86134349 |
81 | sulfur amino acid catabolic process (GO:0000098) | 2.85157904 |
82 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.84396702 |
83 | negative regulation of protein localization to cell surface (GO:2000009) | 2.84307844 |
84 | glutamate metabolic process (GO:0006536) | 2.83786552 |
85 | positive regulation of fatty acid oxidation (GO:0046321) | 2.83516208 |
86 | protein localization to endosome (GO:0036010) | 2.82443995 |
87 | fatty acid oxidation (GO:0019395) | 2.81512203 |
88 | response to lipoprotein particle (GO:0055094) | 2.79724133 |
89 | tyrosine metabolic process (GO:0006570) | 2.79407744 |
90 | lipid oxidation (GO:0034440) | 2.77293531 |
91 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.76852911 |
92 | acyl-CoA metabolic process (GO:0006637) | 2.76225876 |
93 | thioester metabolic process (GO:0035383) | 2.76225876 |
94 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.76189558 |
95 | negative regulation of adherens junction organization (GO:1903392) | 2.74498167 |
96 | negative regulation of focal adhesion assembly (GO:0051895) | 2.74498167 |
97 | negative regulation of cell junction assembly (GO:1901889) | 2.74498167 |
98 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.74169631 |
99 | monocarboxylic acid catabolic process (GO:0072329) | 2.72778486 |
100 | reverse cholesterol transport (GO:0043691) | 2.72455762 |
101 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.72272727 |
102 | cholesterol efflux (GO:0033344) | 2.71084295 |
103 | cell-cell junction maintenance (GO:0045217) | 2.71046313 |
104 | astrocyte development (GO:0014002) | 2.69943669 |
105 | regulation of fibrinolysis (GO:0051917) | 2.69904789 |
106 | dicarboxylic acid catabolic process (GO:0043649) | 2.68848271 |
107 | alpha-amino acid catabolic process (GO:1901606) | 2.67721665 |
108 | import into cell (GO:0098657) | 2.67482087 |
109 | adenosine receptor signaling pathway (GO:0001973) | 2.67305569 |
110 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.67208165 |
111 | ketone body metabolic process (GO:1902224) | 2.65302420 |
112 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.64758475 |
113 | positive regulation of receptor recycling (GO:0001921) | 2.64297435 |
114 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.64192750 |
115 | tryptophan catabolic process (GO:0006569) | 2.64098923 |
116 | indole-containing compound catabolic process (GO:0042436) | 2.64098923 |
117 | indolalkylamine catabolic process (GO:0046218) | 2.64098923 |
118 | regulation of protein activation cascade (GO:2000257) | 2.64044709 |
119 | myelination in peripheral nervous system (GO:0022011) | 2.63441949 |
120 | peripheral nervous system axon ensheathment (GO:0032292) | 2.63441949 |
121 | aromatic amino acid family metabolic process (GO:0009072) | 2.62811686 |
122 | cortical cytoskeleton organization (GO:0030865) | 2.62556851 |
123 | iron coordination entity transport (GO:1901678) | 2.62202356 |
124 | endocytic recycling (GO:0032456) | 2.62058440 |
125 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.61713636 |
126 | substrate-dependent cell migration (GO:0006929) | 2.60822578 |
127 | glycerophospholipid catabolic process (GO:0046475) | 2.60296160 |
128 | cofactor catabolic process (GO:0051187) | 2.60082302 |
129 | cholesterol homeostasis (GO:0042632) | 2.60061924 |
130 | embryo implantation (GO:0007566) | 2.59919152 |
131 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.59892096 |
132 | cell volume homeostasis (GO:0006884) | 2.59530305 |
133 | sterol biosynthetic process (GO:0016126) | 2.58593158 |
134 | establishment of mitochondrion localization (GO:0051654) | 2.57807693 |
135 | cellular amino acid catabolic process (GO:0009063) | 2.57302922 |
136 | cellular modified amino acid catabolic process (GO:0042219) | 2.57223600 |
137 | modulation by symbiont of host cellular process (GO:0044068) | 2.56528023 |
138 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.56450932 |
139 | sterol homeostasis (GO:0055092) | 2.56382871 |
140 | negative regulation of lipase activity (GO:0060192) | 2.56032302 |
141 | triglyceride homeostasis (GO:0070328) | 2.55807822 |
142 | acylglycerol homeostasis (GO:0055090) | 2.55807822 |
143 | regulation of extracellular matrix organization (GO:1903053) | 2.55333590 |
144 | response to laminar fluid shear stress (GO:0034616) | 2.54250816 |
145 | amyloid precursor protein metabolic process (GO:0042982) | 2.53952461 |
146 | amino-acid betaine metabolic process (GO:0006577) | 2.53498166 |
147 | regulation of sequestering of triglyceride (GO:0010889) | 2.53407723 |
148 | cholesterol metabolic process (GO:0008203) | 2.53166302 |
149 | plasma lipoprotein particle remodeling (GO:0034369) | 2.52958562 |
150 | protein-lipid complex remodeling (GO:0034368) | 2.52958562 |
151 | macromolecular complex remodeling (GO:0034367) | 2.52958562 |
152 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.51496977 |
153 | low-density lipoprotein particle clearance (GO:0034383) | 2.50607193 |
154 | negative regulation of fatty acid transport (GO:2000192) | 2.49823715 |
155 | hyaluronan catabolic process (GO:0030214) | 2.48763320 |
156 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.48689188 |
157 | mannose metabolic process (GO:0006013) | 2.47512201 |
158 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.47075552 |
159 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.46808195 |
160 | endothelial cell chemotaxis (GO:0035767) | 2.46219147 |
161 | actin filament bundle organization (GO:0061572) | 2.45770474 |
162 | actin filament bundle assembly (GO:0051017) | 2.45770474 |
163 | chondrocyte proliferation (GO:0035988) | 2.42115115 |
164 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.41843382 |
165 | paraxial mesoderm development (GO:0048339) | 2.39882825 |
166 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.38488916 |
167 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.38099334 |
168 | protein heterotrimerization (GO:0070208) | 2.36616170 |
169 | decidualization (GO:0046697) | 2.36298392 |
170 | cellular protein complex localization (GO:0034629) | 2.34031720 |
171 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.33505414 |
172 | amino acid import (GO:0043090) | 2.32925156 |
173 | adhesion of symbiont to host (GO:0044406) | 2.32869939 |
174 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.31675854 |
175 | positive regulation of nuclease activity (GO:0032075) | 2.31575764 |
176 | negative regulation of anoikis (GO:2000811) | 2.29231576 |
177 | modulation by virus of host morphology or physiology (GO:0019048) | 2.28816786 |
178 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.27970934 |
179 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.27224421 |
180 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.27083315 |
181 | glycosphingolipid catabolic process (GO:0046479) | 2.26383498 |
182 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.24431483 |
183 | membrane protein ectodomain proteolysis (GO:0006509) | 2.24358916 |
184 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.23689265 |
185 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.23635458 |
186 | venous blood vessel morphogenesis (GO:0048845) | 2.22944057 |
187 | glial cell migration (GO:0008347) | 2.22640135 |
188 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.21595732 |
189 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.20682722 |
190 | virion attachment to host cell (GO:0019062) | 2.20578594 |
191 | adhesion of symbiont to host cell (GO:0044650) | 2.20578594 |
192 | collagen metabolic process (GO:0032963) | 2.19531048 |
193 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.19300876 |
194 | regulation of response to osmotic stress (GO:0047484) | 2.19265064 |
195 | positive regulation of osteoblast proliferation (GO:0033690) | 2.18413500 |
196 | blood vessel endothelial cell migration (GO:0043534) | 2.18209655 |
197 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.17467827 |
198 | cell migration involved in heart development (GO:0060973) | 2.17438666 |
199 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.17018264 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.60314459 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.99102759 |
3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.53114161 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.48994970 |
5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.48197960 |
6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.35231263 |
7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.90553565 |
8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.79931434 |
9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.59641099 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.40261065 |
11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.08709942 |
12 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.02436058 |
13 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.99153670 |
14 | MYC_22102868_ChIP-Seq_BL_Human | 1.96336200 |
15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.93039303 |
16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.92620252 |
17 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.90031304 |
18 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.87375827 |
19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.85720692 |
20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.83140839 |
21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.82939700 |
22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82294328 |
23 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60379819 |
24 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58703737 |
25 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.57362764 |
26 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.55292816 |
27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51657564 |
28 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.50131703 |
29 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44359140 |
30 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.43714560 |
31 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.42984033 |
32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.42411440 |
33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42150656 |
34 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.39411815 |
35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39261034 |
36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39161835 |
37 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.37613402 |
38 | GATA1_19941826_ChIP-Seq_K562_Human | 1.36332475 |
39 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.36203380 |
40 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.35983101 |
41 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.35069407 |
42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33188583 |
43 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.32871839 |
44 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.32871839 |
45 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.32871839 |
46 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.32789455 |
47 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.31985603 |
48 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.31985603 |
49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31898467 |
50 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31173966 |
51 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29590246 |
52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29566539 |
53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29446762 |
54 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.28916708 |
55 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28595863 |
56 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.27699014 |
57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26947208 |
58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26868821 |
59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26241352 |
60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.26176953 |
61 | ATF3_27146783_Chip-Seq_COLON_Human | 1.25227001 |
62 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.23855885 |
63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23799791 |
64 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.23720144 |
65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22528723 |
66 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.20911475 |
67 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.20911475 |
68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20324652 |
69 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.20138199 |
70 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.19593617 |
71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18925824 |
72 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.18807061 |
73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18367247 |
74 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.18263655 |
75 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.18014638 |
76 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.17332787 |
77 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17174206 |
78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15750557 |
79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15750557 |
80 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.15617909 |
81 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.14651516 |
82 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14001231 |
83 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13086788 |
84 | KDM2B_26808549_Chip-Seq_K562_Human | 1.12533119 |
85 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.12516638 |
86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12409707 |
87 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11557080 |
88 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.10204854 |
89 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09955438 |
90 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.09457267 |
91 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09322476 |
92 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.08333625 |
93 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08310516 |
94 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08197304 |
95 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07947866 |
96 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07417131 |
97 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.07187700 |
98 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05156873 |
99 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05137643 |
100 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04085891 |
101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03170356 |
102 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.03166519 |
103 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01697524 |
104 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01464838 |
105 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00560294 |
106 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00547324 |
107 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00492910 |
108 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00392107 |
109 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99725635 |
110 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.98941127 |
111 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98611860 |
112 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98553321 |
113 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.98461263 |
114 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.98197426 |
115 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97273864 |
116 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97272664 |
117 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96153136 |
118 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95484816 |
119 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95418777 |
120 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95270087 |
121 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95115487 |
122 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94968839 |
123 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.94707561 |
124 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94016699 |
125 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.93380317 |
126 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92264591 |
127 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.91964509 |
128 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.91964509 |
129 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.91959099 |
130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91119460 |
131 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89851254 |
132 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89607671 |
133 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.89521317 |
134 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89453045 |
135 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88764874 |
136 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.87887858 |
137 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.86921987 |
138 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85805234 |
139 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.85297345 |
140 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85287758 |
141 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84327185 |
142 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84050072 |
143 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.83718146 |
144 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.82129609 |
145 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81920392 |
146 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81175127 |
147 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.80394996 |
148 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80249396 |
149 | CJUN_26792858_Chip-Seq_BT549_Human | 0.78732518 |
150 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77769586 |
151 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77125059 |
152 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77013121 |
153 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.76432001 |
154 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.75569592 |
155 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.75200383 |
156 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.75081026 |
157 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.74884266 |
158 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.74762466 |
159 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.74640229 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.75276780 |
2 | MP0005360_urolithiasis | 4.12314527 |
3 | MP0000920_abnormal_myelination | 3.57349185 |
4 | MP0009840_abnormal_foam_cell | 3.50635836 |
5 | MP0005085_abnormal_gallbladder_physiolo | 3.39959203 |
6 | MP0003566_abnormal_cell_adhesion | 3.24578324 |
7 | MP0003690_abnormal_glial_cell | 3.21609502 |
8 | MP0003806_abnormal_nucleotide_metabolis | 3.17974561 |
9 | MP0005365_abnormal_bile_salt | 3.02501293 |
10 | MP0005257_abnormal_intraocular_pressure | 2.92156149 |
11 | MP0008438_abnormal_cutaneous_collagen | 2.87653432 |
12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.77126798 |
13 | MP0002877_abnormal_melanocyte_morpholog | 2.53784690 |
14 | MP0003300_gastrointestinal_ulcer | 2.49651744 |
15 | MP0003091_abnormal_cell_migration | 2.49520305 |
16 | MP0003252_abnormal_bile_duct | 2.39590671 |
17 | MP0003950_abnormal_plasma_membrane | 2.37966693 |
18 | MP0003195_calcinosis | 2.36286351 |
19 | MP0003329_amyloid_beta_deposits | 2.27842964 |
20 | MP0005076_abnormal_cell_differentiation | 2.21522754 |
21 | MP0002254_reproductive_system_inflammat | 2.18441868 |
22 | MP0003191_abnormal_cellular_cholesterol | 2.16150242 |
23 | MP0001849_ear_inflammation | 2.12968788 |
24 | MP0010329_abnormal_lipoprotein_level | 2.03581048 |
25 | MP0005332_abnormal_amino_acid | 2.02462427 |
26 | MP0003303_peritoneal_inflammation | 2.01619881 |
27 | MP0005409_darkened_coat_color | 2.00544074 |
28 | MP0010352_gastrointestinal_tract_polyps | 1.97924156 |
29 | MP0009278_abnormal_bone_marrow | 1.96840868 |
30 | MP0005023_abnormal_wound_healing | 1.96837295 |
31 | MP0003453_abnormal_keratinocyte_physiol | 1.95423782 |
32 | MP0004510_myositis | 1.91715833 |
33 | MP0000604_amyloidosis | 1.90698496 |
34 | MP0002118_abnormal_lipid_homeostasis | 1.85469847 |
35 | MP0005058_abnormal_lysosome_morphology | 1.82504141 |
36 | MP0005083_abnormal_biliary_tract | 1.79705466 |
37 | MP0002998_abnormal_bone_remodeling | 1.73990626 |
38 | MP0005451_abnormal_body_composition | 1.72248886 |
39 | MP0002837_dystrophic_cardiac_calcinosis | 1.70850165 |
40 | MP0004130_abnormal_muscle_cell | 1.69488282 |
41 | MP0003634_abnormal_glial_cell | 1.63807767 |
42 | MP0004036_abnormal_muscle_relaxation | 1.59413286 |
43 | MP0000751_myopathy | 1.58816046 |
44 | MP0000747_muscle_weakness | 1.55630591 |
45 | MP0004885_abnormal_endolymph | 1.55535787 |
46 | MP0005330_cardiomyopathy | 1.50963990 |
47 | MP0005670_abnormal_white_adipose | 1.49128691 |
48 | MP0005666_abnormal_adipose_tissue | 1.48442251 |
49 | MP0010368_abnormal_lymphatic_system | 1.48130197 |
50 | MP0004233_abnormal_muscle_weight | 1.46891829 |
51 | MP0001915_intracranial_hemorrhage | 1.46158486 |
52 | MP0004185_abnormal_adipocyte_glucose | 1.45642971 |
53 | MP0002896_abnormal_bone_mineralization | 1.45370229 |
54 | MP0004272_abnormal_basement_membrane | 1.43457577 |
55 | MP0004084_abnormal_cardiac_muscle | 1.42736275 |
56 | MP0003448_altered_tumor_morphology | 1.40462888 |
57 | MP0002089_abnormal_postnatal_growth/wei | 1.37789257 |
58 | MP0008260_abnormal_autophagy | 1.36518716 |
59 | MP0005623_abnormal_meninges_morphology | 1.36104471 |
60 | MP0000858_altered_metastatic_potential | 1.35335011 |
61 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.31867426 |
62 | MP0005508_abnormal_skeleton_morphology | 1.28740380 |
63 | MP0005167_abnormal_blood-brain_barrier | 1.28340775 |
64 | MP0002060_abnormal_skin_morphology | 1.26462041 |
65 | MP0006138_congestive_heart_failure | 1.23661809 |
66 | MP0002295_abnormal_pulmonary_circulatio | 1.23079984 |
67 | MP0005375_adipose_tissue_phenotype | 1.22394242 |
68 | MP0000609_abnormal_liver_physiology | 1.21586019 |
69 | MP0001958_emphysema | 1.20740522 |
70 | MP0001666_abnormal_nutrient_absorption | 1.19652474 |
71 | MP0004087_abnormal_muscle_fiber | 1.19325348 |
72 | MP0003705_abnormal_hypodermis_morpholog | 1.18050629 |
73 | MP0003656_abnormal_erythrocyte_physiolo | 1.15861654 |
74 | MP0003436_decreased_susceptibility_to | 1.12724665 |
75 | MP0003632_abnormal_nervous_system | 1.12670000 |
76 | MP0003075_altered_response_to | 1.11072620 |
77 | MP0001533_abnormal_skeleton_physiology | 1.09983864 |
78 | MP0003941_abnormal_skin_development | 1.09569386 |
79 | * MP0005464_abnormal_platelet_physiology | 1.09397005 |
80 | MP0004808_abnormal_hematopoietic_stem | 1.08350728 |
81 | MP0006054_spinal_hemorrhage | 1.06420648 |
82 | MP0003828_pulmonary_edema | 1.06363982 |
83 | MP0000749_muscle_degeneration | 1.04795568 |
84 | MP0005390_skeleton_phenotype | 1.03686896 |
85 | MP0003633_abnormal_nervous_system | 1.03668796 |
86 | MP0008004_abnormal_stomach_pH | 0.99957652 |
87 | MP0004947_skin_inflammation | 0.99633703 |
88 | MP0005319_abnormal_enzyme/_coenzyme | 0.99442963 |
89 | MP0005621_abnormal_cell_physiology | 0.99096754 |
90 | * MP0005595_abnormal_vascular_smooth | 0.97101801 |
91 | MP0000003_abnormal_adipose_tissue | 0.96936310 |
92 | MP0009780_abnormal_chondrocyte_physiolo | 0.96572171 |
93 | MP0003631_nervous_system_phenotype | 0.96453710 |
94 | MP0002972_abnormal_cardiac_muscle | 0.96318245 |
95 | MP0009672_abnormal_birth_weight | 0.95390949 |
96 | MP0003137_abnormal_impulse_conducting | 0.91691491 |
97 | MP0010630_abnormal_cardiac_muscle | 0.90565204 |
98 | MP0009053_abnormal_anal_canal | 0.90460028 |
99 | MP0001853_heart_inflammation | 0.90193988 |
100 | MP0001614_abnormal_blood_vessel | 0.89341740 |
101 | MP0004085_abnormal_heartbeat | 0.88082458 |
102 | MP0001542_abnormal_bone_strength | 0.87721696 |
103 | MP0002229_neurodegeneration | 0.87397988 |
104 | MP0003279_aneurysm | 0.87101112 |
105 | MP0000428_abnormal_craniofacial_morphol | 0.86991504 |
106 | MP0004270_analgesia | 0.86406534 |
107 | MP0009643_abnormal_urine_homeostasis | 0.85006797 |
108 | MP0001348_abnormal_lacrimal_gland | 0.84327773 |
109 | MP0010234_abnormal_vibrissa_follicle | 0.84251805 |
110 | MP0000537_abnormal_urethra_morphology | 0.82183339 |
111 | MP0002796_impaired_skin_barrier | 0.81980581 |
112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81463008 |
113 | MP0002971_abnormal_brown_adipose | 0.81368034 |
114 | MP0001544_abnormal_cardiovascular_syste | 0.81364045 |
115 | MP0005385_cardiovascular_system_phenoty | 0.81364045 |
116 | MP0010307_abnormal_tumor_latency | 0.80409333 |
117 | MP0004043_abnormal_pH_regulation | 0.80108221 |
118 | MP0004134_abnormal_chest_morphology | 0.79392125 |
119 | MP0001545_abnormal_hematopoietic_system | 0.79121203 |
120 | MP0005397_hematopoietic_system_phenotyp | 0.79121203 |
121 | MP0010030_abnormal_orbit_morphology | 0.78651384 |
122 | MP0001661_extended_life_span | 0.78454180 |
123 | MP0002090_abnormal_vision | 0.77139521 |
124 | MP0000534_abnormal_ureter_morphology | 0.76364095 |
125 | MP0000462_abnormal_digestive_system | 0.76347424 |
126 | MP0010678_abnormal_skin_adnexa | 0.75912025 |
127 | * MP0001730_embryonic_growth_arrest | 0.75771038 |
128 | MP0002925_abnormal_cardiovascular_devel | 0.75496990 |
129 | MP0005501_abnormal_skin_physiology | 0.75157907 |
130 | MP0005647_abnormal_sex_gland | 0.75115140 |
131 | MP0003795_abnormal_bone_structure | 0.74916891 |
132 | MP0005275_abnormal_skin_tensile | 0.74636580 |
133 | MP0001243_abnormal_dermal_layer | 0.73886798 |
134 | MP0003172_abnormal_lysosome_physiology | 0.72928857 |
135 | MP0003115_abnormal_respiratory_system | 0.72783924 |
136 | MP0004858_abnormal_nervous_system | 0.72193463 |
137 | MP0008775_abnormal_heart_ventricle | 0.71266404 |
138 | MP0006082_CNS_inflammation | 0.70743249 |
139 | MP0003942_abnormal_urinary_system | 0.70370656 |
140 | MP0009384_cardiac_valve_regurgitation | 0.70270387 |
141 | MP0002113_abnormal_skeleton_development | 0.69668501 |
142 | MP0001177_atelectasis | 0.69521915 |
143 | MP0005197_abnormal_uvea_morphology | 0.68941877 |
144 | MP0002269_muscular_atrophy | 0.68913283 |
145 | MP0004859_abnormal_synaptic_plasticity | 0.68754744 |
146 | MP0004019_abnormal_vitamin_homeostasis | 0.67450015 |
147 | MP0005165_increased_susceptibility_to | 0.67433390 |
148 | MP0000639_abnormal_adrenal_gland | 0.67367425 |
149 | MP0005408_hypopigmentation | 0.67263482 |
150 | MP0002128_abnormal_blood_circulation | 0.65978140 |
151 | MP0004142_abnormal_muscle_tone | 0.63981792 |
152 | * MP0005620_abnormal_muscle_contractility | 0.63910325 |
153 | MP0008874_decreased_physiological_sensi | 0.62961963 |
154 | MP0000733_abnormal_muscle_development | 0.61965559 |
155 | MP0001486_abnormal_startle_reflex | 0.61676448 |
156 | MP0003646_muscle_fatigue | 0.61239842 |
157 | MP0002108_abnormal_muscle_morphology | 0.60616917 |
158 | MP0005503_abnormal_tendon_morphology | 0.59279983 |
159 | MP0005388_respiratory_system_phenotype | 0.58961244 |
160 | MP0002133_abnormal_respiratory_system | 0.58961244 |
161 | * MP0000230_abnormal_systemic_arterial | 0.58753274 |
162 | MP0000343_altered_response_to | 0.58131135 |
163 | MP0002064_seizures | 0.56850007 |
164 | MP0000767_abnormal_smooth_muscle | 0.56684098 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Neurofibrillary tangles (HP:0002185) | 4.81014825 |
2 | Deep venous thrombosis (HP:0002625) | 4.59470217 |
3 | Protrusio acetabuli (HP:0003179) | 4.47176891 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.35103790 |
5 | Intrahepatic cholestasis (HP:0001406) | 4.35085364 |
6 | Xanthomatosis (HP:0000991) | 4.19604488 |
7 | Cerebral inclusion bodies (HP:0100314) | 3.80765771 |
8 | Complement deficiency (HP:0004431) | 3.79427537 |
9 | Hyperlipoproteinemia (HP:0010980) | 3.77581697 |
10 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.66971597 |
11 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.66971597 |
12 | Axonal loss (HP:0003447) | 3.58204429 |
13 | Vertebral compression fractures (HP:0002953) | 3.10554038 |
14 | Ankle contracture (HP:0006466) | 3.09655130 |
15 | Hyperacusis (HP:0010780) | 3.08015828 |
16 | Muscle fiber splitting (HP:0003555) | 2.99383855 |
17 | Abnormality of the corticospinal tract (HP:0002492) | 2.98369137 |
18 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.95345512 |
19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.95345512 |
20 | Abnormality of glycolipid metabolism (HP:0010969) | 2.95345512 |
21 | Abnormality of glycine metabolism (HP:0010895) | 2.94073139 |
22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.94073139 |
23 | Hyperammonemia (HP:0001987) | 2.93597520 |
24 | Supranuclear gaze palsy (HP:0000605) | 2.92238295 |
25 | Hyporeflexia of lower limbs (HP:0002600) | 2.90702036 |
26 | Onion bulb formation (HP:0003383) | 2.90610387 |
27 | Vascular tortuosity (HP:0004948) | 2.85365638 |
28 | Ketosis (HP:0001946) | 2.83726970 |
29 | Insidious onset (HP:0003587) | 2.83003583 |
30 | Termporal pattern (HP:0011008) | 2.83003583 |
31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.81327350 |
32 | Arterial tortuosity (HP:0005116) | 2.79099196 |
33 | Epidermoid cyst (HP:0200040) | 2.76398708 |
34 | Systemic lupus erythematosus (HP:0002725) | 2.75965747 |
35 | Genu recurvatum (HP:0002816) | 2.62731567 |
36 | Cerebral hemorrhage (HP:0001342) | 2.60837690 |
37 | Cerebral aneurysm (HP:0004944) | 2.60609934 |
38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.57837605 |
39 | Abnormality of complement system (HP:0005339) | 2.56859909 |
40 | Spinal rigidity (HP:0003306) | 2.53874200 |
41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.53270260 |
42 | Fragile skin (HP:0001030) | 2.53260892 |
43 | Obstructive sleep apnea (HP:0002870) | 2.51275607 |
44 | Bladder diverticulum (HP:0000015) | 2.50026480 |
45 | Peripheral hypomyelination (HP:0007182) | 2.49245611 |
46 | Nuclear cataract (HP:0100018) | 2.47969105 |
47 | Dysostosis multiplex (HP:0000943) | 2.47298279 |
48 | Intention tremor (HP:0002080) | 2.45486008 |
49 | Prolonged partial thromboplastin time (HP:0003645) | 2.44880201 |
50 | Broad metatarsal (HP:0001783) | 2.42406817 |
51 | Ulnar bowing (HP:0003031) | 2.42194350 |
52 | Hypoalphalipoproteinemia (HP:0003233) | 2.39672418 |
53 | Cervical subluxation (HP:0003308) | 2.39053126 |
54 | Hyperglycinuria (HP:0003108) | 2.38981560 |
55 | Atrophic scars (HP:0001075) | 2.37576595 |
56 | Peripheral demyelination (HP:0011096) | 2.37555545 |
57 | Wormian bones (HP:0002645) | 2.37153356 |
58 | Abnormal gallbladder physiology (HP:0012438) | 2.35860855 |
59 | Cholecystitis (HP:0001082) | 2.35860855 |
60 | Insomnia (HP:0100785) | 2.31808511 |
61 | Blue sclerae (HP:0000592) | 2.31734454 |
62 | Aortic dissection (HP:0002647) | 2.30628031 |
63 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.28485887 |
64 | Mitral regurgitation (HP:0001653) | 2.26254383 |
65 | Amyloidosis (HP:0011034) | 2.26086637 |
66 | Skin nodule (HP:0200036) | 2.23512315 |
67 | Hypobetalipoproteinemia (HP:0003563) | 2.22519409 |
68 | Upper limb amyotrophy (HP:0009129) | 2.22176128 |
69 | Distal upper limb amyotrophy (HP:0007149) | 2.22176128 |
70 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.22125303 |
71 | Hyperglycinemia (HP:0002154) | 2.21973421 |
72 | Difficulty running (HP:0009046) | 2.21568574 |
73 | Ketoacidosis (HP:0001993) | 2.21060582 |
74 | Spondylolisthesis (HP:0003302) | 2.20735078 |
75 | Premature rupture of membranes (HP:0001788) | 2.18766339 |
76 | Aortic aneurysm (HP:0004942) | 2.18395315 |
77 | Turricephaly (HP:0000262) | 2.17728756 |
78 | Dilatation of the ascending aorta (HP:0005111) | 2.16750669 |
79 | Hypoglycemic coma (HP:0001325) | 2.16167962 |
80 | Abnormality of methionine metabolism (HP:0010901) | 2.13616185 |
81 | Hypolipoproteinemia (HP:0010981) | 2.13181295 |
82 | Abnormal gallbladder morphology (HP:0012437) | 2.11010613 |
83 | Asymmetry of the thorax (HP:0001555) | 2.10950239 |
84 | Delayed CNS myelination (HP:0002188) | 2.08746558 |
85 | Fat malabsorption (HP:0002630) | 2.07528071 |
86 | Hypercholesterolemia (HP:0003124) | 2.07335406 |
87 | Foot dorsiflexor weakness (HP:0009027) | 2.06860410 |
88 | Sudden death (HP:0001699) | 2.05769708 |
89 | Spastic gait (HP:0002064) | 2.05561183 |
90 | Sensory axonal neuropathy (HP:0003390) | 2.04754809 |
91 | Broad face (HP:0000283) | 2.04712320 |
92 | Glomerulonephritis (HP:0000099) | 2.04445303 |
93 | Osteolytic defects of the hand bones (HP:0009699) | 2.01755553 |
94 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01755553 |
95 | Stridor (HP:0010307) | 2.01421934 |
96 | Distal lower limb amyotrophy (HP:0008944) | 2.01117995 |
97 | Disproportionate tall stature (HP:0001519) | 2.00857114 |
98 | Hyperextensible skin (HP:0000974) | 2.00584307 |
99 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.00554922 |
100 | Cholelithiasis (HP:0001081) | 2.00332256 |
101 | Mitral valve prolapse (HP:0001634) | 1.99886422 |
102 | Abnormality of the Achilles tendon (HP:0005109) | 1.99338277 |
103 | Increased connective tissue (HP:0009025) | 1.98893915 |
104 | Bowel diverticulosis (HP:0005222) | 1.98294219 |
105 | Spastic tetraparesis (HP:0001285) | 1.97731948 |
106 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.97702239 |
107 | Mucopolysacchariduria (HP:0008155) | 1.97501804 |
108 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.97501804 |
109 | Hammertoe (HP:0001765) | 1.97355529 |
110 | Aneurysm (HP:0002617) | 1.97306423 |
111 | Vascular calcification (HP:0004934) | 1.97074627 |
112 | Myocardial infarction (HP:0001658) | 1.95076905 |
113 | Abnormal auditory evoked potentials (HP:0006958) | 1.95024514 |
114 | Arnold-Chiari malformation (HP:0002308) | 1.94990517 |
115 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94605838 |
116 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94605838 |
117 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94605838 |
118 | Abnormality of the common coagulation pathway (HP:0010990) | 1.94349080 |
119 | Protuberant abdomen (HP:0001538) | 1.93905849 |
120 | Pheochromocytoma (HP:0002666) | 1.93260679 |
121 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.93030897 |
122 | Renal duplication (HP:0000075) | 1.91924265 |
123 | Exercise-induced muscle cramps (HP:0003710) | 1.91079189 |
124 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.90818513 |
125 | Cardiovascular calcification (HP:0011915) | 1.89291146 |
126 | Syringomyelia (HP:0003396) | 1.89120700 |
127 | Spinal cord lesions (HP:0100561) | 1.89120700 |
128 | Abnormality of dentin (HP:0010299) | 1.88472197 |
129 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88465909 |
130 | Abnormality of the foot musculature (HP:0001436) | 1.87277175 |
131 | Joint hemorrhage (HP:0005261) | 1.86758737 |
132 | Exercise-induced myalgia (HP:0003738) | 1.86256193 |
133 | Thin bony cortex (HP:0002753) | 1.86168224 |
134 | Joint laxity (HP:0001388) | 1.85607453 |
135 | Apathy (HP:0000741) | 1.84339593 |
136 | Hyperparathyroidism (HP:0000843) | 1.84113290 |
137 | Slender build (HP:0001533) | 1.84018288 |
138 | Loss of speech (HP:0002371) | 1.82168809 |
139 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.81630469 |
140 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.81555619 |
141 | Dicarboxylic aciduria (HP:0003215) | 1.81555619 |
142 | Short nail (HP:0001799) | 1.81507387 |
143 | Distal lower limb muscle weakness (HP:0009053) | 1.81164594 |
144 | Dysmetria (HP:0001310) | 1.80272708 |
145 | Flat acetabular roof (HP:0003180) | 1.79759380 |
146 | Ankle clonus (HP:0011448) | 1.79646388 |
147 | Paraparesis (HP:0002385) | 1.78970620 |
148 | Neonatal short-limb short stature (HP:0008921) | 1.78594196 |
149 | Myoglobinuria (HP:0002913) | 1.78503322 |
150 | Diminished motivation (HP:0000745) | 1.77918995 |
151 | Biconcave vertebral bodies (HP:0004586) | 1.77665413 |
152 | Lower limb amyotrophy (HP:0007210) | 1.77466030 |
153 | Overriding aorta (HP:0002623) | 1.76127508 |
154 | Steatorrhea (HP:0002570) | 1.74846244 |
155 | Congenital glaucoma (HP:0001087) | 1.74839971 |
156 | Neuronal loss in central nervous system (HP:0002529) | 1.74513421 |
157 | Generalized amyotrophy (HP:0003700) | 1.73364200 |
158 | Long palpebral fissure (HP:0000637) | 1.72022701 |
159 | Back pain (HP:0003418) | 1.70257956 |
160 | Abnormal ossification of hand bones (HP:0005921) | 1.69762724 |
161 | Soft skin (HP:0000977) | 1.69369414 |
162 | Coronal craniosynostosis (HP:0004440) | 1.67710110 |
163 | Achilles tendon contracture (HP:0001771) | 1.67615249 |
164 | Natal tooth (HP:0000695) | 1.67595089 |
165 | EMG: myopathic abnormalities (HP:0003458) | 1.66788296 |
166 | Buphthalmos (HP:0000557) | 1.66064038 |
167 | Ankyloglossia (HP:0010296) | 1.64783944 |
168 | Shallow orbits (HP:0000586) | 1.64583490 |
169 | Mitral stenosis (HP:0001718) | 1.64442253 |
170 | Increased variability in muscle fiber diameter (HP:0003557) | 1.64301960 |
171 | Polygenic inheritance (HP:0010982) | 1.64122835 |
172 | Spastic paraparesis (HP:0002313) | 1.63872423 |
173 | Ventricular tachycardia (HP:0004756) | 1.63817616 |
174 | Increased cerebral lipofuscin (HP:0011813) | 1.63689672 |
175 | Abnormality of the thoracic spine (HP:0100711) | 1.63131007 |
176 | Rapidly progressive (HP:0003678) | 1.62268995 |
177 | Hand muscle atrophy (HP:0009130) | 1.62229845 |
178 | Advanced eruption of teeth (HP:0006288) | 1.61840657 |
179 | Abnormality of oral frenula (HP:0000190) | 1.60647346 |
180 | Bone pain (HP:0002653) | 1.60439743 |
181 | Elfin facies (HP:0004428) | 1.58793461 |
182 | Cupped ribs (HP:0000887) | 1.58689416 |
183 | Abnormality of the acetabulum (HP:0003170) | 1.57997317 |
184 | Hypoventilation (HP:0002791) | 1.56653972 |
185 | Abnormality of carpal bone ossification (HP:0006257) | 1.56421880 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 4.22937333 |
2 | EPHB1 | 3.60222586 |
3 | IRAK3 | 3.43587958 |
4 | OXSR1 | 2.61705551 |
5 | TRIB3 | 2.53232021 |
6 | SMG1 | 2.30151182 |
7 | BCKDK | 2.30037419 |
8 | PKN1 | 2.24216360 |
9 | MET | 2.23921576 |
10 | FGFR2 | 2.16651683 |
11 | TAOK2 | 2.14607394 |
12 | MAPKAPK5 | 2.05547243 |
13 | WNK4 | 1.96603191 |
14 | ICK | 1.92297584 |
15 | LMTK2 | 1.86548638 |
16 | NME2 | 1.84509661 |
17 | NTRK1 | 1.75504913 |
18 | CDK12 | 1.74194078 |
19 | PAK4 | 1.67907437 |
20 | TESK1 | 1.65496876 |
21 | TTN | 1.65293775 |
22 | DMPK | 1.64100439 |
23 | PHKG2 | 1.60966948 |
24 | PHKG1 | 1.60966948 |
25 | PKN2 | 1.60466036 |
26 | WNK1 | 1.58028557 |
27 | ARAF | 1.57711112 |
28 | KSR2 | 1.51198691 |
29 | EEF2K | 1.45937423 |
30 | PAK6 | 1.43590689 |
31 | PRKD3 | 1.43227754 |
32 | SIK1 | 1.41616071 |
33 | MAP2K3 | 1.39302991 |
34 | PRKD1 | 1.36227473 |
35 | SGK223 | 1.35288681 |
36 | SGK494 | 1.35288681 |
37 | TIE1 | 1.33317581 |
38 | CDC42BPA | 1.33129474 |
39 | PTK6 | 1.25407737 |
40 | LIMK1 | 1.23805882 |
41 | ROCK2 | 1.23527146 |
42 | MOS | 1.22512378 |
43 | CSNK1A1L | 1.21592920 |
44 | CAMK1G | 1.20732379 |
45 | TYRO3 | 1.18389705 |
46 | CSNK1G3 | 1.18016632 |
47 | EPHA2 | 1.16813055 |
48 | PAK3 | 1.14711765 |
49 | MAP3K9 | 1.12945797 |
50 | CSNK1G1 | 1.08833406 |
51 | TGFBR2 | 1.08657889 |
52 | MAP3K10 | 1.07937036 |
53 | MAP3K3 | 1.03882840 |
54 | NEK9 | 1.03742139 |
55 | UHMK1 | 1.03415387 |
56 | BCR | 1.03312939 |
57 | CAMK2D | 1.03235796 |
58 | TRPM7 | 1.00949780 |
59 | RIPK1 | 1.00629352 |
60 | RPS6KA2 | 0.98505622 |
61 | FGR | 0.98034845 |
62 | MAP3K13 | 0.97914252 |
63 | PRKD2 | 0.96684106 |
64 | MAP3K7 | 0.95330836 |
65 | BMX | 0.94123016 |
66 | CAMK1D | 0.93726979 |
67 | CSNK1G2 | 0.91810575 |
68 | EPHB2 | 0.90565379 |
69 | PDPK1 | 0.90457087 |
70 | CLK1 | 0.89024901 |
71 | PDGFRA | 0.89019443 |
72 | PRPF4B | 0.87671415 |
73 | MAP3K6 | 0.87395902 |
74 | ERBB4 | 0.87023372 |
75 | PRKCH | 0.86399701 |
76 | TAOK1 | 0.84372116 |
77 | DDR2 | 0.84142676 |
78 | MAPK15 | 0.83588511 |
79 | MAP3K11 | 0.82689114 |
80 | LATS1 | 0.81798316 |
81 | FGFR4 | 0.81415050 |
82 | PINK1 | 0.81236843 |
83 | CAMK2B | 0.78929599 |
84 | PTK2B | 0.78737036 |
85 | CAMK2G | 0.78088067 |
86 | GSK3A | 0.77986545 |
87 | RET | 0.77471522 |
88 | MAP3K14 | 0.77435998 |
89 | MAP3K8 | 0.76554440 |
90 | STK38 | 0.75165760 |
91 | ERN1 | 0.72303205 |
92 | PRKG2 | 0.71714023 |
93 | MAP3K2 | 0.70440934 |
94 | ZAP70 | 0.69613621 |
95 | EPHA4 | 0.69502091 |
96 | PAK2 | 0.68684853 |
97 | SCYL2 | 0.67306430 |
98 | MAPK12 | 0.65829454 |
99 | BRAF | 0.65614278 |
100 | PRKAA2 | 0.62987206 |
101 | ROCK1 | 0.61639673 |
102 | RPS6KC1 | 0.61113578 |
103 | RPS6KL1 | 0.61113578 |
104 | PRKCQ | 0.60839718 |
105 | MAP2K2 | 0.60689388 |
106 | ILK | 0.60560552 |
107 | HIPK2 | 0.58700512 |
108 | TESK2 | 0.57622867 |
109 | MARK2 | 0.57609873 |
110 | PBK | 0.57520953 |
111 | PDK2 | 0.56762844 |
112 | PDGFRB | 0.52512854 |
113 | SGK3 | 0.52359183 |
114 | CAMK2A | 0.51515038 |
115 | PTK2 | 0.51256791 |
116 | PDK1 | 0.50858586 |
117 | CSF1R | 0.50719593 |
118 | TBK1 | 0.50120634 |
119 | PRKACB | 0.49766757 |
120 | IRAK2 | 0.49527600 |
121 | CDK6 | 0.48101557 |
122 | CDK5 | 0.47971662 |
123 | MATK | 0.47821654 |
124 | DAPK3 | 0.47507822 |
125 | LATS2 | 0.46040570 |
126 | MAPK7 | 0.45624302 |
127 | OBSCN | 0.45071658 |
128 | STK11 | 0.44955311 |
129 | CDK9 | 0.44349689 |
130 | CDK14 | 0.43950336 |
131 | PRKCZ | 0.43743014 |
132 | MTOR | 0.43521158 |
133 | FYN | 0.43114198 |
134 | DAPK2 | 0.42157935 |
135 | MAP3K1 | 0.41131839 |
136 | MELK | 0.38266126 |
137 | CDK15 | 0.38262180 |
138 | ALK | 0.38088089 |
139 | ABL2 | 0.37665379 |
140 | MYLK | 0.36536024 |
141 | PIM2 | 0.34014107 |
142 | CDK11A | 0.33674492 |
143 | RPS6KA6 | 0.31024180 |
144 | CDK4 | 0.30204326 |
145 | MAPK10 | 0.28637501 |
146 | FGFR3 | 0.28265465 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.06093469 |
2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.18820654 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.00462347 |
4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.88521000 |
5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.84410788 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.55177323 |
7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.53920634 |
8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.47439282 |
9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.44885813 |
10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.44227103 |
11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.39067152 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36737322 |
13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.32472564 |
14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.28794653 |
15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.23723506 |
16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.19701814 |
17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.09173599 |
18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.04364302 |
19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.91458382 |
20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87822832 |
21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.87251288 |
22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.86400924 |
23 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.82803421 |
24 | Bladder cancer_Homo sapiens_hsa05219 | 1.82781951 |
25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.79553340 |
26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74772961 |
27 | Peroxisome_Homo sapiens_hsa04146 | 1.54005564 |
28 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.53374049 |
29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51821570 |
30 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.48853124 |
31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47541914 |
32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.46136822 |
33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.45934490 |
34 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.45033252 |
35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.44854813 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.42897787 |
37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42422860 |
38 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.41686059 |
39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.39583382 |
40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37554780 |
41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36440081 |
42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36438544 |
43 | Endometrial cancer_Homo sapiens_hsa05213 | 1.35481358 |
44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.35104737 |
45 | Adherens junction_Homo sapiens_hsa04520 | 1.33156203 |
46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.30799524 |
47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.23917401 |
48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22954638 |
49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.18271424 |
50 | Shigellosis_Homo sapiens_hsa05131 | 1.17650994 |
51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16826456 |
52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16009940 |
53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14798972 |
54 | Glioma_Homo sapiens_hsa05214 | 1.13985340 |
55 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.12922498 |
56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.12795142 |
57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.12413862 |
58 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.12246207 |
59 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.12197612 |
60 | Salmonella infection_Homo sapiens_hsa05132 | 1.11916793 |
61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.11753390 |
62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09708603 |
63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08072319 |
64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06294842 |
65 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06245213 |
66 | Malaria_Homo sapiens_hsa05144 | 1.05645786 |
67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05351375 |
68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04779911 |
69 | Thyroid cancer_Homo sapiens_hsa05216 | 1.04472151 |
70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03983929 |
71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02565443 |
72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97845795 |
73 | ABC transporters_Homo sapiens_hsa02010 | 0.97061980 |
74 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.96683646 |
75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.96401414 |
76 | Prostate cancer_Homo sapiens_hsa05215 | 0.96263393 |
77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95877213 |
78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94268442 |
79 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92436087 |
80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.91985426 |
81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90500478 |
82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.89496373 |
83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89122948 |
84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.88314609 |
85 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.88181654 |
86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88022147 |
87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.87930629 |
88 | Gap junction_Homo sapiens_hsa04540 | 0.87808252 |
89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85914221 |
90 | Hepatitis C_Homo sapiens_hsa05160 | 0.85841951 |
91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.85789479 |
92 | Pertussis_Homo sapiens_hsa05133 | 0.84955506 |
93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83580564 |
94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83373736 |
95 | Retinol metabolism_Homo sapiens_hsa00830 | 0.83330124 |
96 | Hepatitis B_Homo sapiens_hsa05161 | 0.82248823 |
97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81068855 |
98 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80626594 |
99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80300006 |
100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79695170 |
101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.78441067 |
102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78218336 |
103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77977797 |
104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76964943 |
105 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76615398 |
106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76589870 |
107 | Prion diseases_Homo sapiens_hsa05020 | 0.76348896 |
108 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75095307 |
109 | Lysine degradation_Homo sapiens_hsa00310 | 0.74950954 |
110 | Melanoma_Homo sapiens_hsa05218 | 0.74443592 |
111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71705437 |
112 | Platelet activation_Homo sapiens_hsa04611 | 0.71402234 |
113 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.70846626 |
114 | Leishmaniasis_Homo sapiens_hsa05140 | 0.69255543 |
115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68904052 |
116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68065059 |
117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67821203 |
118 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66790175 |
119 | Phagosome_Homo sapiens_hsa04145 | 0.66304893 |
120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66286075 |
121 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.65552759 |
122 | Tuberculosis_Homo sapiens_hsa05152 | 0.64639419 |
123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64062498 |
124 | Apoptosis_Homo sapiens_hsa04210 | 0.63700148 |
125 | Lysosome_Homo sapiens_hsa04142 | 0.63492380 |
126 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63214494 |
127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62761496 |
128 | Influenza A_Homo sapiens_hsa05164 | 0.61727521 |
129 | Melanogenesis_Homo sapiens_hsa04916 | 0.61093625 |
130 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60806443 |
131 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57998273 |
132 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57995848 |
133 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.55707757 |
134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54973909 |
135 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54816908 |
136 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54783563 |
137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54750468 |
138 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53614721 |
139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53484436 |
140 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53455275 |
141 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53214142 |
142 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52085076 |
143 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51934767 |
144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51375964 |
145 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51091458 |
146 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50030913 |
147 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42844546 |
148 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41694851 |
149 | Axon guidance_Homo sapiens_hsa04360 | 0.40512049 |
150 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38305032 |
151 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38033092 |
152 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37919259 |
153 | Insulin resistance_Homo sapiens_hsa04931 | 0.37208743 |
154 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34633223 |
155 | Focal adhesion_Homo sapiens_hsa04510 | 0.33762401 |
156 | Tight junction_Homo sapiens_hsa04530 | 0.32844446 |
157 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.31313621 |
158 | Amoebiasis_Homo sapiens_hsa05146 | 0.30820789 |
159 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30188141 |
160 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29951665 |
161 | Endocytosis_Homo sapiens_hsa04144 | 0.27899659 |
162 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26965659 |
163 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.25671357 |
164 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25399684 |
165 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24585233 |
166 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.24035697 |
167 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.23326138 |
168 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.22993671 |
169 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20074052 |
170 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.14026852 |
171 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13777842 |
172 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.13552313 |
173 | Cocaine addiction_Homo sapiens_hsa05030 | 0.11960165 |
174 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.11830737 |
175 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.10154123 |
176 | GABAergic synapse_Homo sapiens_hsa04727 | 0.09786541 |
177 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.09317290 |
178 | Sulfur relay system_Homo sapiens_hsa04122 | 0.09055157 |